PCSK9 and hypertriglyceridemia: Although statins, the intestinal cholesterol transporter inhibitor (namely, ezetimibe) and PCSK9 inhibitors reduce serum levels of LDL-C, they do not act on Hypertriglyceridemia and HDL levels.